Does AMLODIPINE Cause Application site vesicles? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Application site vesicles have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.0% of all adverse event reports for AMLODIPINE.
5
Reports of Application site vesicles with AMLODIPINE
0.0%
of all AMLODIPINE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Application site vesicles From AMLODIPINE?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Application site vesicles Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE Cause?
Hypotension (6,504)
Toxicity to various agents (5,554)
Completed suicide (5,267)
Drug ineffective (4,091)
Dyspnoea (3,907)
Dizziness (3,536)
Intentional overdose (3,427)
Fall (3,215)
Fatigue (3,141)
Headache (2,907)
What Other Drugs Cause Application site vesicles?
INGENOL MEBUTATE (843)
BUPRENORPHINE (700)
SUMATRIPTAN (262)
NICOTINE (241)
MINOXIDIL (188)
ESTRADIOL (179)
FENTANYL (170)
PICATO (139)
DICLOFENAC (115)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (80)
Which AMLODIPINE Alternatives Have Lower Application site vesicles Risk?
AMLODIPINE vs AMLODIPINE BESILATE
AMLODIPINE vs AMLODIPINE\ATORVASTATIN
AMLODIPINE vs AMLODIPINE\BENAZEPRIL
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL